ライフサイエンスコーパス: whites

1 r teenage motherhood of black girls (40% for whites).

2 s and odds ratio, 1.06; 95% CI, 0.80-1.41 in whites).

3 served among ethnic groups (Blacks>Hispanics>Whites).

4 25), which reduces ANP (atrial-NP) levels in whites.

5 8) years for blacks and 54.4 (5.7) years for whites.

6 T and virally suppressed, respectively, than whites.

7 ess risk of SCD in blacks in comparison with whites.

8 rimary care and emergency visits compared to whites.

9 eased incidence of LT, compared with younger whites.

10 to increases in rectal cancer, especially in whites.

11 04; 95% CI, 0.88-1.22; P=0.66) compared with whites.

12 g and mortality after delisting than younger whites.

13 and lower sleep continuity in comparison to Whites.

14 years, 56.2% were female, and 25.5% were non-whites.

15 e highest for blacks, followed by non-Latino whites.

16 udden cardiac death (SCD) in comparison with whites.

17 has a higher morbidity and mortality than in whites.

18 prilysin (MME) and miR-425 among blacks than whites.

19 (P trend=0.047) greater in 2013 relative to whites.

20 greater (P trend=0.004) in 2013 relative to whites.

21 pressure, respectively, in GERA non-Hispanic whites.

22 lower risk of colorectal cancer-mostly among whites.

23 , 0.57-1.18) was associated with CVD risk in whites.

24 hort was 54 years, with 61% females, and 56% whites.

25 o compare the proportions between blacks and whites.

26 ng CVD deaths in non-Hispanic blacks than in whites.

27 rates of hypertension control compared with whites.

28 Americans, Japanese Americans, Latinos, and whites.

29 se, and Filipino) compared with non-Hispanic whites.

30 heart disease (CHD) mortality compared with whites.

31 blacks, Hispanics, and Asians compared with whites.

32 , African Americans have outcomes similar to Whites.

33 ns and Alaska Natives were close to those of whites.

34 xperience greater poststroke disability than whites.

35 and 13 mg/dL (95% CI, 11-16) lower LDL-C in whites.

36 CI, 1.04 to 1.54) compared with non-Hispanic whites.

37 ported in a large population of asymptomatic whites.

38 2) in blacks and 0.82 (95% CI, 0.63-1.06) in whites.

39 nder patients had the highest, compared with whites.

40 ong nonwhites and 19 percentage points among whites.

41 ted with a survival advantage for Blacks and Whites.

42 ife expectancy between African Americans and whites.

43 n alcohol consumption traits in non-Hispanic whites.

44 3% (P trend=0.021) lower in 2013 relative to whites.

45 panic Blacks in comparison with non-Hispanic Whites.

46 owledging increased disease burden among non-whites.

47 r annual costs ($-336, P=0.77) compared with whites.

48 in the higher risk of HF among blacks versus whites.

49 ars and the black group 9 years younger than whites.

50 ere significantly greater than zero only for whites.

51 ssions among African Americans compared with Whites.

52 .87]) were less likely to receive LVADs than whites.

53 same pattern of dialysis discontinuation as whites.

54 er's disease (AD) dementia than non-Hispanic whites.

55 nd Hispanics than estimates for non-Hispanic whites.

56 Asians had a higher risk than Whites.

57 dence interval [CI] = 0.81-1.62) compared to whites.

58 ective tissue disorders is more prevalent in Whites.

59 ssociated with IL-6 among AA and IL-10 among Whites.

60 7%) were AAs, whereas 23.4% of patients were Whites.

61 s TOPS 0.21 [95% CI, -0.18 to 0.60] and PLRS whites 0.27 [95% CI, -0.04 to 0.58]).

62 ersus TOPS 0.23 [95% CI, 0.15-0.31] and PLRS whites 0.60 [95% CI, 0.33-0.87]).

63 racial/ethnic groups other than non-Hispanic whites (0.09, 0.04-0.2).

64 Risk allele frequency in whites (0.43) was greater than in Chinese (0.24), transl

65 , 95% CI [-0.28, -0.12], p < 0.001) than for whites (-0.09 SD/decade, 95% CI [-0.16, -0.02], p = 0.00

66 Black participants (HR for Q4 versus Q1 for Whites, 0.49 [95% CI, 0.35-0.69]; for Blacks, 1.22 [95%

67 0.65; men, 1.04; women, 0.36; Blacks, 0.90; Whites, 0.50; up to/through high-school education, 1.00;

68 interval (CI): 1.15, 1.44) for non-Hispanic whites, 1.67 (95% CI: 1.20, 2.34) for non-Hispanic black

69 significant for mRNFL comparing blacks with whites: -1.65 mum [95% CI, -1.86 to -1.43]; P = 2.4x10(-

70 ICH was more common in Hispanics (14.6%) and Whites (10.1%) as compared to Asians (1.2%).

71 16 elderly renal transplant recipients (all whites; 10 men; mean age, 64 +/- 2 years (61-71 years),

72 udy population comprised mostly non-Hispanic whites (1153 patients, 74%), so the primary analysis foc

73 , 95% confidence interval [CI] 1291-1635) vs Whites (1793, 95% CI 1678-1916; P = .002) and Hispanics

74 d whole eggs (18 g protein, 17 g fat) or egg whites (18 g protein, 0 g fat).

75 ly higher (3.6%, P = 0.049) when compared to Whites (2.6%) and Asians (2.9%).

76 fference in absolute percentage points among whites (2.6%) and blacks (4.8%) whereas refusals were hi

77 ispanics/Latinx)=2.95 [2.42-3.61], and PR(NH-Whites)=2.66 [2.44-2.89]).

78 I, 11.8% to 21.2%) and CHEK2 (breast cancer: whites, 2.3%; 95% CI, 1.8% to 2.8%; v blacks, 0.1%; 95%

79 n than for men (10.4% vs. 3.7%), blacks than whites (21.7% vs. 6.9%), and, although associations were

80 296 decedents: 147 Blacks, 64 Hispanics, 49 Whites, 22 Asians, and 14 mixed ethnicities; 142 infants

81 ic blacks (13.6%) compared with non-Hispanic whites (25.8%; adjusted prevalence ratio: 0.63 [0.61-0.6

82 Optimal birth weight was greatest in Whites (3,890 g), and least in South Asians (3,491 g).

83 of MAN was 21.0% (95% CI, 18.4% to 23.9%) in whites, 32.2% (CI, 27.3% to 37.4%) in Chinese Americans,

84 Among normal-weight participants (n = 846 whites, 323 Chinese Americans, 334 African Americans, 25

85 patients were identified: Blacks (67.0%) and Whites (33.0%).

86 in blacks (21.6%; 95% CI, 18.1% to 25.4%; v whites, 33.8%; 95% CI, 32.3% to 35.3%) and uninsured pat

87 by race (blacks 23% [95% CI, 19%-27%] versus whites 34% [95% CI, 31%-38]; P(interaction)<0.001), with

88 o 72%; P < .001 for trend), as well as among whites (39% to 86%; P < .001 for trend) and nonwhites (3

89 ater among Hispanics than among non-Hispanic whites (4.2% vs. 1.2%, P<0.001).

90 The prevalence of SPD was 3.4% for NH-Whites, 4.1% for NH-Blacks, and 4.5% for Hispanics/Latin

91 d age were 21.4% in mixed ethnicities, 10.2% Whites, 4.5% Asians, 3.1% Hispanics, and 2% Blacks; 7.7%

92 s included race (hazard ratio for Asians vs. Whites, 4.84; 95% CI, 3.57 to 6.56), height, weight, and

93 of Blacks had Medicaid insurance compared to Whites (40% versus 20%, p = 0.0002) and Blacks had lower

94 Among Whites 45 to 54 years of age, the median SBP was 18 mm H

95 002) and Blacks had lower median income than Whites ($45,710 versus $54,844, p = 0.01).

96 h), Bi-/multi-racial (48.0 +/- 16.0 h), and Whites (50.2 +/- 2.6 h).

97 AF after 14.4 years' follow-up was 11.3% in whites, 6.6% in African Americans, 7.8% in Hispanics, an

98 ingestion of whole eggs (68% +/- 1%) and egg whites (66% +/- 2%), with no difference in whole-body ne

99 nic variants included BRCA1 (ovarian cancer: whites, 7.2%; 95% CI, 5.9% to 8.8%; v Hispanics, 16.1%;

100 95% CI: 72.6-81.9), followed by non-Hispanic whites (70.1%, 95% CI: 66.9-73.1).

101 associated with lower metabolic syndrome for whites across all levels of childhood disadvantage.

102 uation patterns similar to those found among whites across racial and ethnic groups, differences in s

103 In conclusion, compared with non-Hispanic whites, AD incidence and persistence are higher among ce

104 cs had similar mortality rates compared with whites (adjusted hazard ratio, 0.92; 95% CI, 0.76-1.11 a

105 Compared with non-Hispanic whites, Hispanic whites (adjusted odds ratio [AOR] 0.36; 95% confidence i

106 more likely in African Americans compared to whites (adjusted odds ratio, 1.3; 95% CI, 1.2-1.5), pati

107 and likelihood of LDKT increased by 70% for whites [adjusted hazard ratio (aHR) 1.70; 95% confidence

108 djusted MD = 0.08 (95% CI: -0.34, 0.50); for Whites, adjusted MD = -0.03 (95% CI: -0.18, 0.11)) in mi

109 confidence interval (CI): -0.13, 0.19); for Whites, adjusted MD = 0.02 (95% CI: -0.05, 0.08)) and st

110 ower (P < 0.001) as compared to non-ACOs for whites, African Americans, Hispanics, and Asians in both

111 comes for African Americans as compared with Whites after 12 major surgical procedures across multipl

112 Hawaiians, Japanese Americans, Latinos, and whites aged 45 to 75 years at recruitment.

113 n Asians/Pacific Islanders than non-Hispanic whites (aIRR = 2.09); after induction immunosuppression

114 imilar associations in African Americans and whites (all ps < 0.03).

115 6.9%, and 5.2%, respectively (compared with whites, all P>0.5).

116 Compared with whites, all racial/ethnic minority groups had a statisti

117 Results for poor whites also show that toxic environments independently p

118 justed variation in log(BMI) was 0.055 among Whites and 0.066 among Blacks.

119 African-Americans (AAs)], 30 caregivers (17 whites and 13 AAs), and 20 providers (8 residents, 4 nur

120 and for current smoking, 12% (7%-16%) among whites and 18% (11%-22%) among blacks.

121 Forty patients [20 whites and 20 African-Americans (AAs)], 30 caregivers (1

122 ; for diabetes mellitus, 14% (10%-20%) among whites and 31% (28%-41%) among blacks; and for current s

123 DM).The longitudinal cohort consisted of 609 whites and 339 blacks who had BMI and fasting insulin me

124 onses (PEAR) (50 whites) and from PEAR-2 (50 whites and 50 blacks).

125 5th percentile of SBP decreased 60 mm Hg for Whites and 70 mm Hg for Blacks.

126 llows: for hypertension, 49% (45%-58%) among whites and 72% (68%-78%) among blacks; for diabetes mell

127 g/m2): 28.3 +/- 1.3; age: 35.2 +/- 6.3 y; 88 whites and 83 blacks] enrolled in a weight-loss program

128 adenocarcinoma rate rose among non-Hispanic whites and among black men.

129 revalence rates were generally highest among Whites and among those of higher socioeconomic status (S

130 associated with increased odds of GDM among whites and APIs.

131 indings, mostly from studies of non-Hispanic whites and Asians, are inconsistent.

132 orpus cancer were similar among non-Hispanic whites and blacks and lower among Hispanics and Asians/P

133 has decreased in recent years among US born whites and blacks but not in other race/ethnicities and

134 ugh most of the decrease occurred in US-born whites and blacks but not the foreign-born or those born

135 % versus 24.8%, P < 0.001), and non-Hispanic whites and blacks were more likely to have had any opioi

136 MetS severity seems highly heritable among whites and blacks.

137 TMAO concentration did not differ between whites and blacks.

138 a cancer incidence is higher in non-Hispanic whites and does not vary substantially by nSES.

139 ctional cohort of African Americans (AA) and whites and found no significant differences in EV size,

140 uits, we find 37 +/- 6% higher NO(2) for non-whites and Hispanics living in low-income tracts (LIN) c

141 lent in the west Southeast and Midwest among whites and in the north among blacks.

142 This pattern contrasts starkly with whites and minorities from more privileged backgrounds,

143 stronger multimorbidity network followed by Whites and Native Americans.

144 asons for higher cardia risk in non-Hispanic whites and targeted interventions to address non-cardia

145 ion of Antihypertensive Responses (PEAR) (50 whites) and from PEAR-2 (50 whites and 50 blacks).

146 increase for black male income rank (70% for whites), and a 17% increase for teenage motherhood of bl

147 sians, 45.3% Hispanics, 44.20% Blacks, 36.7% Whites, and 14.3% in mixed ethnicities.

148 5.5 years, 14 (70%) were male, 13 (65%) were whites, and 8 (38%) had previous kidney transplants.

149 c minorities on dialysis survive longer than whites, and are less likely to discontinue dialysis.

150 han previously unscreened African Americans, whites, and Hispanics 51-56 years old.

151 ad poorer hypertension control compared with whites, and these differences were more pronounced in yo

152 er likelihood seen among males, non-Hispanic whites, and those living in poverty.

153 time cumulative risk of SCD among blacks and whites, and to evaluate the risk factors that may explai

154 articipants (58.5% males; 68.6% non-Hispanic whites; and 46.6% allogeneic BMT recipients).

155 nts were at higher odds of death compared to whites (aOR 1.69, 95%CI 1.00-2.86).

156 Disparities are noted whereby whites are more likely to die in hospice facilities or a

157 te-associated atypical fractures occurred in Whites, as compared with 91 and 8, respectively, in Asia

158 ave earlier oral sexual debuts compared with Whites (b = 2.67; 95% CI: 1.21, -4.13).

159 , 95% CI = -6.63 to -1.31) than non-Hispanic whites (beta = -0.40, 95% CI = -4.18 to 3.39, p-interact

160 s (beta=4.789; adjusted P<0.001), but not in whites (beta=1.051; adjusted P=0.283).

161 wide significant association in non-Hispanic whites between the previously reported SNP rs1229984 in

162 Compared with whites, blacks (OR, 0.89; 95% CI, 0.86-0.92) and Latinos

163 Compared with whites, blacks had smaller increases in relative surviva

164 icantly across CAC categories in men, women, Whites, Blacks, and Hispanics (all P<0.001).

165 uring the study period, all 3 racial groups (whites, blacks, and Hispanics) experienced substantial i

166 seen among men; middle and older age groups; whites, blacks, and Hispanics; and the socioeconomically

167 The cohort included non-Hispanic whites, blacks, Hispanics, and Asians.

168 of cadmium, lead, mercury, and arsenic than whites, blacks, Mexican Americans, and other Hispanics i

169 he increased risk of atypical fracture among Whites but less so among Asians.

170 born Latinos compared to US-born Latinos and Whites but unclear for other racial/ethnic minority grou

171 ricans are hyposensitive to pain compared to Whites, but African Americans show increased pain sensit

172 ost prevalent in the central Southeast among whites, but in the west Southeast among blacks.

173 er in African Americans than in non-Hispanic whites, but whether adding information on parathyroid ho

174 Compared with non-Hispanic whites, cardia cancer multivariable-adjusted incidence r

175 era of hepatitis C virus infection and among whites/Caucasians.

176 As compared with Whites, Chinese HCM patients commonly have low penetranc

177 nterval: 12, 47) increased odds of GDM among whites compared with 45% (95% confidence interval: 16, 8

178 S, the new FSRP was a better predictor among whites compared with blacks.

179 sparities in healthcare outcomes compared to Whites despite high quality cirrhosis care.

180 cally detected atrial fibrillation (AF) than whites, despite a higher prevalence of major AF risk fac

181 tein synthesis than did the ingestion of egg whites, despite being matched for protein content in you

182 in blacks and better in Asians compared with whites, despite taking into account socioeconomic factor

183 bility variants was higher in blacks than in whites (difference, 0.24; P = 2.3 x 10-5), while the est

184 risk score was much higher in blacks than in whites (difference, 0.48; P = 2.8 x 10-11).

185 after the consumption of whole eggs with egg whites during exercise recovery in young men.In crossove

186 rimination salient increased the accuracy of Whites' estimates of Black-White economic equality, wher

187 s of kidney transplantation (KT) compared to Whites, even after adjusting for demographic and medical

188 On average, non-Hispanic whites experience a "pollution advantage": They experien

189 dvantage operates every year on the scale of Whites' experience of COVID-19, then so too should the t

190 27.4 years of follow-up, 215 blacks and 332 whites experienced SCD.

191 similar rates of mental disorder relative to whites) extends across 12 lifetime and past-year psychia

192 Among whites, FFIs (change = 0.15; Ptrend < 0.0001) and NFIs (

193 Whites followed by Asians represented the highest percen

194 risk was significantly higher for APIs than whites for most VOCs.

195 in black and Asian females to match that in whites for vaccination; cervical screening in women who

196 ancer incidence increased among non-Hispanic whites from 2003 to 2015 and among non-Hispanic blacks,

197 e hypothesis in a subset of 143 non-Hispanic Whites from a randomized controlled trial of patients wi

198 , and a network trained only in non-Hispanic whites from the original derivation cohort performed sim

199 shift in systolic BP (SBP) among Blacks and Whites from the Southeast between 1960 and 2005 with the

200 The increase in rectal cancer was larger in whites (from 2.7 to 4.5 per 100,000) than in blacks (fro

201 viously reported ABI and PAD associations in whites generalized to Hispanics/Latinos.

202 All AAs and older whites had decreased incidence of LT, compared with youn

203 Older whites had higher incidence of waitlist mortality than y

204 ic blacks (P-trend < .001), but non-Hispanic whites had higher rates of MBS utilization (45.8%) compa

205 00,000); in the 2010-2014 period, blacks and whites had similar rates of rectal cancer.

206 Yet, Whites had the highest mean birth weight and South Asian

207 Compared with non-Hispanic whites, Hispanic whites (adjusted odds ratio [AOR] 0.36;

208 in four race/ethnicity groups: non-Hispanic whites, Hispanic/Latinos, East Asians and African Americ

209 of previously unscreened African Americans, whites, Hispanics, and Asian/Pacific Islanders who were

210 Islanders but were stable among non-Hispanic whites; however, nonendometrioid carcinoma rates rose si

211 estimate survival in minorities relative to whites if minorities had the same pattern of dialysis di

212 panic blacks surpassed those of non-Hispanic whites in 2007.

213 tions remained 37% higher for nonwhites than whites in 2010 (40% higher in 2000), and nonwhites were

214 omen, 240% (P trend=0.725) with reference to whites in 2013 with no significant change between 2002 a

215 tions among minority patients as compared to whites in ACOs and non-ACOs between 2009 to 2011 and 201

216 d of receiving palliative care compared with whites in any hospital stratum, but the odds of palliati

217 5-, ~2.5-, and ~2-fold higher in blacks than whites in atrial tissues, respectively.

218 frequencies of dialysis discontinuation than whites in each hospitalization cohort.

219 There were no immediate changes in whites in either state group following the ACA Medicaid

220 dence and CHD case-fatality among blacks and whites in the Atherosclerosis Risk in Communities study

221 rvival outcome difference between blacks and whites in The Cancer Genome Atlas data set.

222 Compared with blacks in the same quintile, whites in the highest quintile for TMAO (>/=135 muM) had

223 se Americans, Latinos, native Hawaiians, and whites in the Multiethnic Cohort (MEC).

224 icantly greater among African Americans than whites in the United States.

225 ificantly lower in African Americans than in whites, in both unadjusted and risk factor-adjusted anal

226 rticipants tended to make more requests than whites (IRR 1.65, 95% CI [0.99-2.73], P = 0.05).

227 iving in low-income tracts (LIN) compared to whites living in high-income tracts (HIW) and report NO(

228 for non-Hispanic Blacks versus non-Hispanic Whites (mean annual decrease 2.3% versus 2.6%, respectiv

229 y Composition participants (48.5% men; 59.6% whites; mean age, 73.6+/-2.9 years), 111 developed incid

230 erage characterized by a higher frequency of whites, Medicare beneficiaries, and lower rates of cardi

231 Among whites, models 1 to 4 all showed similar O:E ratios, sug

232 iscrimination (29.0% vs 15.7%, P < .01) than whites (n = 121), blacks were only slightly less likely

233 nts with cirrhosis were identified including Whites (n = 241), Hispanics (n = 106), Blacks (n = 50),

234 rage survival rates compared to non-Hispanic Whites (NHW).

235 ney transplantation compared to non-Hispanic whites (NHWs).

236 Compared to non-Hispanic whites, non-Hispanic blacks (aOR = 2.71, 95% confidence

237 Compared with Whites, odds for incident AKI were not significantly hig

238 l was persistently lower for blacks than for whites of all ages, and awareness, treatment, and contro

239 , and Native Americans at a higher risk than Whites of being diagnosed with EE in the setting of Cand

240 otal) (Delta: annual rate of increase) among Whites only.

241 2.14-3.72) were considerably higher than in Whites (OR = 1.09, 95% CI = 0.88-1.34; OR = 1.44, 95% CI

242 1.73, 2.24; P < 0.001) than in non-Hispanic whites (OR = 1.54, 95% CI: 1.25, 1.91; P < 0.001) and bl

243 OR=5.90, CI=1.89-25.96) than in non-Hispanic whites (OR=2.10 CI= 0.69-7.13).

244 63 +/- 13.4 compared to 75.7 +/- 23 years in Whites (P < 0.001).

245 < 0.03) but with cancer mortality only among whites (P for trend < 0.0001).

246 , 47%, and 18% lower in blacks compared with whites (P<=0.01), respectively.

247 greater extent than did the ingestion of egg whites (P= 0.04).We show that the ingestion of whole egg

248 .1 +/- 13.4 days vs 7.7 +/- 23 days) than in Whites, P = 0.01.

249 ups was assault (77.3% in Blacks vs in 45.4% Whites; P<0.001), followed by unintentional (21.1% vs 35

250 is a cohort study of 3832 blacks and 11 237 whites participating in the Atherosclerosis Risk in Comm

251 much higher risk for SCD in comparison with whites, particularly among women.

252 significance (24%, P<0.0001), as compared to Whites (pathogenic/likely pathogenic: 31%, excess of var

253 Effect estimates were higher in blacks than whites (PCS x race interaction-beta=0.22; 95%CI:-0.62,1.

254 receiving no glaucoma testing compared with whites possessing commercial health insurance (OR = 2.98

255 ls have a lower risk of hearing loss than do whites, possibly because of differences in cochlear mela

256 Since 1989, whites receive on average 36% more callbacks than Africa

257 Healthy self-identified blacks and whites received 3 days of study diet followed by a high-

258 re encountered between African Americans and Whites receiving surgery at hospitals administered by th

259 ion but similar mortality when compared with whites regardless of digoxin use.

260 ere similar in black women and lower than in whites, regardless of menopausal status.

261 ngaged in the same prevention behaviors, but whites reported being more likely to use digital tools t

262 traordinarily successful for both Blacks and Whites residing in a high-risk region of the United Stat

263 %, 1.3% and 3.9% lower in blacks compared to whites, respectively.

264 prior assessment in California non-Hispanic whites showed substantial increases in invasive melanoma

265 Among women aged 18-29 years, whites spent 12.0% (95% confidence interval [CI], 1.1%-2

266 incidence of waitlist mortality than younger whites (subdistribution hazard ratio, 1.07; 95% confiden

267 were more rapid after the consumption of egg whites than after whole eggs (P = 0.01).

268 However, among Whites the association was linear and graded whereas amo

269 ent MAN prevalence at a BMI of 25.0 kg/m2 in whites, the corresponding BMI values were 22.9 kg/m2 (CI

270 White economic equality, whereas encouraging Whites to anchor their estimates on their own circumstan

271 sians were less likely than South Asians and whites to attain leadership positions, whereas South Asi

272 d older whites were more likely than younger whites to be delisted and to die after delisting.

273 African Americans were more likely than whites to develop PAU (relative risk = 11.3; P < 0.0001)

274 , whereas South Asians were more likely than whites to do so.

275 later life, blacks are also more likely than whites to have experienced the death of a child and of a

276 at blacks are significantly more likely than whites to have experienced the death of a mother, a fath

277 , blacks were only slightly less likely than whites to initiate evaluation (49.6% vs 57.9%, P = .11).

278 nd nonwhites were 2.5 times more likely than whites to live in a block group with an average NO2 conc

279 frican Americans, Hispanics and non-Hispanic Whites using functional magnetic resonance imaging durin

280 6]) versus a medical facility was higher for whites versus blacks.

281 However, neonatal mortality rate in Whites was 0.78 per 1,000 live births, significantly hig

282 d hazard ratio for SCD comparing blacks with whites was 2.12 (95% CI, 1.79-2.51).

283 justed hazard ratios comparing blacks versus whites were 2.61 (95% confidence interval, 1.57-4.34) an

284 ces between racial and ethnic minorities and whites were largely attributable to differences in the f

285 the United States and England and found that whites were less likely to develop systemic EBV disease

286 Both older AAs and older whites were more likely than younger whites to be delist

287 At follow-up, non-Hispanic whites were more likely to consider it highly important

288 (blacks, Asians, Hispanics, and non-Hispanic whites) were targeted for recruitment.

289 of kidney transplantation (KT) compared with Whites (WH), even after adjusting for demographic and me

290 anic African Americans (AA) and non-Hispanic Whites (WH).

291 nocarcinoma is more frequent in non-Hispanic whites, whereas esophageal squamous cell carcinoma with

292 carcinoma rates were highest in non-Hispanic whites, whereas nonendometrioid carcinoma and sarcoma ra

293 much higher rates of ESRD than HIV-positive whites, which could be attributed to the APOL1 renal ris

294 AAs have worse outcomes compared to whites while facing heart diseases, stroke, cancer, asth

295 Odds ratio 0.74 CI95% 0.58-0.94) compared to Whites whilst those with greater educational levels were

296 ticipants randomized, 1702 were non-Hispanic whites who completed the trial and had genotype data for

297 dition, blacks' mental health advantage over whites widened after adjusting for socioeconomic factors

298 at least 1 Y142X or C679X variant and 31 306 whites with 955 (3.1%) having at least 1 R46L variant.

299 After adjustment for confounders, whites with OAG enrolled in Medicaid had 198% higher odd

300 is nearly 2.5-fold higher when compared with Whites, with costs that are significantly higher in the